Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Haemonetics (HAE) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Haemonetics (HAE) over the last 16 years, with Q4 2025 value amounting to 0.53.

  • Haemonetics' Asset Utilization Ratio fell 162.0% to 0.53 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.53, marking a year-over-year decrease of 162.0%. This contributed to the annual value of 0.59 for FY2025, which is 759.23% down from last year.
  • According to the latest figures from Q4 2025, Haemonetics' Asset Utilization Ratio is 0.53, which was down 162.0% from 0.54 recorded in Q3 2025.
  • In the past 5 years, Haemonetics' Asset Utilization Ratio ranged from a high of 0.63 in Q3 2023 and a low of 0.5 during Q3 2021
  • In the last 5 years, Haemonetics' Asset Utilization Ratio had a median value of 0.55 in 2021 and averaged 0.56.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first plummeted by 2970.66% in 2021, then soared by 1497.51% in 2022.
  • Quarter analysis of 5 years shows Haemonetics' Asset Utilization Ratio stood at 0.52 in 2021, then rose by 16.16% to 0.6 in 2022, then decreased by 0.03% to 0.6 in 2023, then dropped by 9.93% to 0.54 in 2024, then fell by 1.62% to 0.53 in 2025.
  • Its Asset Utilization Ratio stands at 0.53 for Q4 2025, versus 0.54 for Q3 2025 and 0.55 for Q2 2025.